As an increasing number of orphan drugs are FDA approved, health care payers, employers, and providers are attempting to strike a balance between patient access to innovative treatments and overall affordability.
Medication nonadherence in individuals with type 2 diabetes can lead to poor glycemic control, resulting in increased risk for diabetes-related complications.
June 2021 News & Views: Register for AMCP's Annual eLearning Days; Medicaid Drug Rebate Program Best Price Rule Delayed; AMCP Foundation Executive Director Paula J. Eichenbrenner, MBA, CAE, Named as Alexandria Chamber of Commerce 40 Under 40 Honoree.
May 2021 News & Views: AMCP Introduces New Strategic Priorities; Defining Our Health Care Future; AMCP Sends Letter of Support for Chiquita Brooks-LaSure's Nomination; Congratulations to the 2021 Steven G. Avey Award Winner Babette Edgar, PharmD, MBA, FAMCP.